Are Placebos Used in Cancer Clinical Trials?

Placebos are the exception, not the ruleExplain▾

If you're weighing whether to join a cancer treatment trial, you might worry about ending up with a placebo — a fake pill or treatment with no active ingredient — instead of real care. The good news: placebos are rarely used in cancer treatment trials.

In most cancer trials, one group receives the new treatment being studied, and another group receives the treatment that's already considered the standard of care for that cancer. Researchers then compare how the two groups do. Nobody in the trial goes without an actual treatment simply for the sake of comparison.

When placebos do show upExplain▾

There are a few specific situations where a placebo might be part of a trial's design:

• When there's no standard treatment available for the condition being studied, so there's nothing established to compare against.
• When researchers are comparing standard treatment plus a placebo against standard treatment plus the study drug — meaning everyone still gets the standard treatment either way.
• In some cancer prevention trials, where participants don't currently have cancer and the study is testing whether an intervention lowers future risk.

Even in these cases, a placebo is only one piece of a much larger, carefully designed study.

You will always be told in advanceExplain▾

Perhaps the most important thing to know is this: if a trial does use a placebo, you are always told ahead of time. This isn't something that gets left out of the conversation or buried in fine print. It's specifically covered in the informed consent process and written into the consent form you review before agreeing to join.

That means you have the chance to ask questions about placebo use before you decide anything. You can ask how likely you are to be assigned to the placebo group, what you would still receive if you were, and why the researchers designed the trial that way.

How this connects to randomization and control groupsExplain▾

Placebo use is closely tied to two other trial concepts: randomization and control groups. Randomization is the process of assigning participants by chance to different groups, and a control group is whichever group serves as the point of comparison. In cancer trials, the control group is usually the group getting the standard treatment — not a placebo. Only in specific circumstances, like the ones above, would a placebo enter the picture at all.

Questions worth asking before you decideExplain▾

If placebo use is a concern for you, it helps to raise it directly and early. Ask the study team:

• Whether this specific trial uses a placebo at all.
• What you would receive if you were assigned to the placebo group.
• How the trial's design accounts for your safety if a placebo is used.

Getting clear, direct answers to these questions before you sign anything can ease a lot of the uncertainty that comes with considering a clinical trial.

Putting your mind at easeExplain▾

Many people are surprised to learn how uncommon placebo use actually is in cancer research, especially compared to trials for other conditions. Because cancer trials usually compare a new approach to an already-approved treatment, most participants know they're receiving real, active cancer care throughout the study — whether they're in the investigational group or the control group. Talking this through with your care team can help you decide whether a particular trial's design feels right for you.